Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)

Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient: a Prospective, Cross-sectional and Open-label 8 Week Switching Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02394392

Acronym

K-HEMS

Enrollment

12691

Registered

2015-03-20

Start date

2014-07-31

Completion date

2015-10-31

Last updated

2016-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Medication satisfaction, Quality of life, Drug compliance

Brief summary

1. Investigate the clinical characteristics, medication satisfaction and quality of life of anti-hypertensive drugs in Korean hypertensive patients 2. Observe the changes of medication satisfaction and compliance in patients after switchting to Fimasartan

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

Step1 * Over 20 years old * Essential hypertensive patients who taking anti-hypertensive drugs during previous 1 month Step2 * Patients does not taking Fimasartan * Patient's medication satisfaction score under 4

Exclusion criteria

* Patients with secondary hypertension * Patients with orthostatic hypotension who has sign and symptom * Patients with known severe or malignancy retinopathy * Patients with significant investigations; abnormal renal function * Childbearing and breast-feeding women * Patients with history of allergic reaction to any angiotensin II antagonist

Design outcomes

Primary

Measure	Time frame
quality of life questionnaire for hypertension	up to 1 month
medication satisfaction questionnaire	up to 8 weeks

Secondary

Measure	Time frame
Drug compliance questionnaire	up to 8 weeks

Countries

South Korea

Outcome results